vs
Side-by-side financial comparison of Invesco Mortgage Capital Inc. (IVR) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $21.3M, roughly 1.9× Invesco Mortgage Capital Inc.). Invesco Mortgage Capital Inc. runs the higher net margin — 242.2% vs 35.9%, a 206.3% gap on every dollar of revenue. On growth, Invesco Mortgage Capital Inc. posted the faster year-over-year revenue change (55.4% vs -10.9%). Over the past eight quarters, Invesco Mortgage Capital Inc.'s revenue compounded faster (74.2% CAGR vs -15.0%).
Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
IVR vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $39.6M |
| Net Profit | $51.5M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | — | 32.5% |
| Net Margin | 242.2% | 35.9% |
| Revenue YoY | 55.4% | -10.9% |
| Net Profit YoY | 1368.7% | 117.2% |
| EPS (diluted) | $0.72 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.3M | $39.6M | ||
| Q3 25 | $17.6M | $43.4M | ||
| Q2 25 | $17.7M | $43.4M | ||
| Q1 25 | $18.8M | $47.3M | ||
| Q4 24 | $13.7M | $44.4M | ||
| Q3 24 | $7.5M | $53.1M | ||
| Q2 24 | $8.6M | $53.1M | ||
| Q1 24 | $7.0M | $54.8M |
| Q4 25 | $51.5M | $14.2M | ||
| Q3 25 | $53.5M | $12.8M | ||
| Q2 25 | $-23.3M | $2.5M | ||
| Q1 25 | $19.6M | $21.5M | ||
| Q4 24 | $3.5M | $6.5M | ||
| Q3 24 | $40.7M | $2.8M | ||
| Q2 24 | $-13.5M | $18.5M | ||
| Q1 24 | $29.1M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | — | 32.5% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 33.6% | ||
| Q1 25 | — | 51.1% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 26.1% | ||
| Q2 24 | — | 51.4% | ||
| Q1 24 | — | 44.6% |
| Q4 25 | 242.2% | 35.9% | ||
| Q3 25 | 303.6% | 29.6% | ||
| Q2 25 | -131.6% | 5.7% | ||
| Q1 25 | 104.4% | 45.4% | ||
| Q4 24 | 25.6% | 14.7% | ||
| Q3 24 | 542.2% | 5.3% | ||
| Q2 24 | -155.9% | 34.8% | ||
| Q1 24 | 415.9% | 34.2% |
| Q4 25 | $0.72 | $0.15 | ||
| Q3 25 | $0.74 | $0.12 | ||
| Q2 25 | $-0.40 | $0.02 | ||
| Q1 25 | $0.26 | $0.21 | ||
| Q4 24 | $-0.09 | $0.05 | ||
| Q3 24 | $0.63 | $0.03 | ||
| Q2 24 | $-0.38 | $0.20 | ||
| Q1 24 | $0.49 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $56.0M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $797.5M | $248.3M |
| Total Assets | $6.5B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.0M | $164.1M | ||
| Q3 25 | $58.5M | $127.4M | ||
| Q2 25 | $59.4M | $152.7M | ||
| Q1 25 | $42.9M | $132.1M | ||
| Q4 24 | $73.4M | $125.0M | ||
| Q3 24 | $48.3M | $137.4M | ||
| Q2 24 | $58.8M | — | ||
| Q1 24 | $59.9M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $797.5M | $248.3M | ||
| Q3 25 | $769.6M | $248.0M | ||
| Q2 25 | $709.4M | $244.6M | ||
| Q1 25 | $759.2M | $226.4M | ||
| Q4 24 | $730.7M | $195.1M | ||
| Q3 24 | $857.0M | $205.0M | ||
| Q2 24 | $759.2M | $8.8M | ||
| Q1 24 | $785.6M | $9.0M |
| Q4 25 | $6.5B | $380.4M | ||
| Q3 25 | $6.0B | $321.4M | ||
| Q2 25 | $5.4B | $315.3M | ||
| Q1 25 | $6.2B | $284.6M | ||
| Q4 24 | $5.7B | $266.1M | ||
| Q3 24 | $6.1B | $296.5M | ||
| Q2 24 | $5.1B | $19.5M | ||
| Q1 24 | $5.2B | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $157.1M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 3.05× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $157.1M | $52.0M | ||
| Q3 25 | $37.3M | $-20.9M | ||
| Q2 25 | $40.6M | $-8.3M | ||
| Q1 25 | $19.3M | $1.9M | ||
| Q4 24 | $183.2M | $-7.3M | ||
| Q3 24 | $30.8M | $5.0M | ||
| Q2 24 | $33.0M | $19.2M | ||
| Q1 24 | $57.5M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | 3.05× | 3.66× | ||
| Q3 25 | 0.70× | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | 0.98× | 0.09× | ||
| Q4 24 | 52.24× | -1.12× | ||
| Q3 24 | 0.76× | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | 1.97× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IVR
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
